8-K: AdaptHealth Appoints New CFO, Transition Underway

AdaptHealth Corp. announced the appointment of Harriss Currie as Chief Financial Officer, effective September 9, 2026, with Jason Clemens transitioning out by October 1, 2026.

Summary

• AdaptHealth Corp. has appointed Harriss Currie as its new Chief Financial Officer (CFO), effective September 9, 2026.
• Jason Clemens will step down as CFO and assist with the transition until October 1, 2026.
• Mr. Currie brings extensive financial leadership experience, including previous CFO roles at Luminex Corp, Health Track Rx, and Impulse Dynamics, as well as a stint as President of 3D Systems' Regenerative Medicine Division.
• His compensation package includes an annual base salary of $670,000, a target annual bonus of 100% of base salary, and a significant initial restricted stock unit (RSU) grant valued at $818,462, with additional equity awards planned from 2027.
• The employment agreement outlines severance benefits in case of termination without cause or for good reason, including continued base salary for 12 months and health insurance continuation.
• Mr. Currie has also entered into a restrictive covenant agreement covering non-compete, non-solicit, confidentiality, and non-disparagement clauses.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, indicating a strategic appointment to a key financial role with experienced leadership.

Positives

• Appointment of an experienced CFO, Harriss Currie, with a strong background in the healthcare and medical device sectors.
• Mr. Currie's compensation package includes a substantial equity component ($818,462 in RSUs) designed to align his interests with shareholders.
• Clear transition plan with Jason Clemens assisting through October 1, 2026, ensuring continuity.
• Management expresses confidence in Mr. Currie's ability to drive future growth and financial performance.
• Mr. Currie's prior experience includes over 15 years as CFO at Luminex Corp, indicating long-term financial stewardship capabilities.

Negatives

• Departure of the current CFO, Jason Clemens, after an unspecified tenure.
• The filing details extensive restrictive covenants for the new CFO, which could impact future career mobility.

Risks

• Potential for disruption during the CFO transition period, although a structured handover is in place.
• The effectiveness of the new CFO in navigating AdaptHealth's specific business challenges and growth strategies remains to be seen.
• Restrictive covenants, while standard, could limit future employment options for Mr. Currie.

Future Outlook

The company anticipates that Mr. Currie's leadership will contribute to future growth and financial performance, with plans for additional equity awards starting in 2027.

Management Comments

• "We are delighted to welcome Harriss to AdaptHealth and look forward to the meaningful contributions we expect he will make in both the short and long term," said Suzanne Foster, Chief Executive Officer.
• "We appreciate Jasons years of service and are particularly thankful for the strong team and structure he has left for Harriss to build on."
• "I am excited to join AdaptHealth and to lead the finance team through our next phase of growth. In evaluating this opportunity, I saw a strong leadership team, solid financial processes, and a business that has put strategic contracts in place to position itself for meaningful revenue and EBITDA growth. I am truly excited and appreciative of this opportunity," said Mr. Currie.

Industry Context

StockSavvy.ai notes that the appointment of a seasoned CFO is a critical step for companies in the healthcare-at-home sector, which is experiencing significant growth and regulatory scrutiny. AdaptHealth's focus on home medical equipment, supplies, and services, including sleep, respiratory, and diabetes health, requires robust financial oversight to manage complex reimbursement models and operational scaling.

Management Changes

Stakeholder Impact

• Shareholders: The appointment of an experienced CFO with a significant equity stake is generally viewed positively, aligning management incentives with shareholder value creation.
• Employees: The transition may create some uncertainty, but the clear handover process and the new CFO's stated focus on growth should provide stability.
• Management: The new CFO's compensation and restrictive covenants are key terms that impact the executive team's financial arrangements and future career options.

Next Steps

• Harriss Currie to assume CFO responsibilities effective September 9, 2026.
• Jason Clemens to assist with the transition until October 1, 2026.
• Mr. Currie to receive initial RSU grant vesting over three years.
• Mr. Currie to be eligible for additional equity awards commencing in 2027.
• Mr. Currie to be subject to restrictive covenants including non-compete and non-solicit clauses.

Key Dates

Recommendation

The filing reports a routine executive appointment and transition, which is expected for a company of this nature. While the new CFO appears well-qualified, there are no significant financial results, strategic shifts, or market-moving events disclosed that would warrant a change in investment recommendation based solely on this filing.

Keywords

Chief Financial Officer, CFO Appointment, Executive Transition, Harriss Currie, Jason Clemens, AdaptHealth Corp, Employment Agreement, Compensation